When the CNS is damaged, such as through stroke, dementia, or brain injury, astrocytes are transformed into reactive astrocytes, such as in hypertrophy and hyperplasia, and GFAP is used to label these reactive astrocytes [50,51,52]. Here, GFAP is linked to dementia.